Our expansive research facilities, state-of-the-art technologies and unique location within The Royal Children’s Hospital, are some of the reasons we’re home to over 1,800 leading researchers and scientists.
Stay informed with the latest research insights, technological advancements and innovations in child health from our research and scientific community.
Discover how you can support us and our partners to help our researchers make life-changing breakthroughs for children.
Search throughout the entire MCRI website to find exactly what you are looking for.
Kidney disease (also called renal disease) is a general term for when the kidneys don’t work properly, causing waste to build up in the body.
Our study aims to assess the immune responses of two different fourth-dose vaccines (bivalent Moderna versus Novavax) among people who have previously received three doses of a COVID-19 vaccine.
This trial is testing Intranasal Heparin to treat early COVID-19 infection.
This study is investigating the biological and cognitive effects of chronic fatigue syndrome in adolescents.
In the IRIS research study, we are looking to find out whether a medication in a research study might improve the social and communication challenges that autistic people might experience.
This study will provide robust evidence of the potential benefits and harms of COVID-19 policies on health outcomes during pregnancy, birth and the first 12 months postnatally; translating these findings into health service provision.
LotusLab: A digital app solution to improve access to information and clinical trials following childhood cancer. LotusLab aims to help families through this time by providing information about childhood cancer experiences and answering questions about life after treatment. The app includes a
Gene discovery program for rare genetic conditions, with a particular focus on neurogenetics and brain development.
A study of 1,933 participants measured current infant feeding practices and whether earlier allergen consumption has reduced the rate of food allergy. In 2023, participants were invited to a six-year follow-up funded by the NHMRC.
This international observational study will provide a landscape analysis of paediatric sepsis across countries with access to different healthcare resources.
Page 76 of 257
